文献速递心外重症与机械循环支持

静脉-动脉体外膜氧合在大面积肺栓塞中的应用

Utilization of Veno-Arterial Extracorporeal Membrane Oxygenation for Massive Pulmonary Embolism.
PubMed 文献 · Ann Thorac Surg · 2017-11-23

院内及90天生存率95%,出院时18/19例右心室功能正常。结论认为VA-ECMO可优化终末器官功能,作为恢复或干预的桥接工具,结局优良。

要点

  • 按方案以VA-ECMO作为大面积肺栓塞初始干预,中位支持5.1天。
  • 最终40%仅抗凝、5%导管定向治疗、55%行外科肺动脉取栓术。
  • 院内及90天生存率95%,出院时18/19例右心室功能正常。

核心结论

  • VA-ECMO可作为优化终末器官功能的桥接工具,为恢复或干预争取时间,结局优良。

主要发现

  • 插管前所有患者右心室与左心室比值大于1.0且存在严重右心室功能障碍。
  • ECMO中位支持时间5.1天,终末器官功能显著改善。
  • 最终40%仅接受抗凝、5%接受导管定向治疗、55%接受外科肺动脉取栓术。
  • 1例插管前长时间心脏骤停患者在确认脑死亡后撤除治疗。
  • 院内及90天生存率95%;出院时18/19例右心室功能正常,1例接受导管定向治疗者轻度功能障碍。

临床怎么用

  • 可按方案以VA-ECMO作为大面积肺栓塞初始干预,待器官功能优化或神经状态明确后再决定后续治疗。
  • 若血栓负荷消退可拔管;若仍有大量血栓且伴右心室应变证据,可行外科治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The management of massive pulmonary embolism remains challenging, with a considerable mortality rate. Although veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for massive pulmonary embolism has been reported, its use as salvage therapy has been associated with poor outcomes. We reviewed our experience utilizing an aggressive, protocolized approach of VA-ECMO to triage, optimize, and treat these patients. METHODS: All patients with a massive pulmonary embolism who were placed on VA-ECMO, as an initial intervention determined by protocol, were retrospectively reviewed. ECMO support was continued until organ optimization was achieved or neurologic status was determined. At that time, if the thrombus burden resolved, decannulation was performed. If substantial clot burden was still present with evidence of right ventricular (RV) strain, operative therapy was undertaken. RESULTS: Twenty patients were identified. Before cannulation, all patients had an RV-to-left ventricular ratio greater than 1.0 and severe RV dysfunction. The median duration of ECMO support was 5.1 days, with significant improvement in end-organ function. Ultimately, 40% received anticoagulation alone, 5% underwent catheter-directed therapy, and 55% underwent surgical pulmonary embolectomy. Care was withdrawn in 1 patient with a prolonged pre-cannulation cardiac arrest after confirmation of neurologic death. In-hospital and 90-day survival was 95%. At discharge, 18 of 19 patients had normal RV function, and 1 patient, who received catheter-directed therapy, had mild dysfunction. CONCLUSIONS: VA-ECMO appears to be an effective tool to optimize end-organ function as a bridge to recovery or intervention, with excellent outcomes. This approach may allow clinicians to better triage patients with massive pulmonary embolism to the appropriate therapy on the basis of recovery of RV function, residual thrombus burden, operative risk, and neurologic status.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Pasrija C, Kronfli A, George P, et al. Utilization of Veno-Arterial Extracorporeal Membrane Oxygenation for Massive Pulmonary Embolism. Ann Thorac Surg. 2017. PMID: 29174781. doi:10.1016/j.athoracsur.2017.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。